… therapies that would impact lipid levels or lipid therapy, and … Patients in the vascular care
team group additionally met with a clinical pharmacist at baseline and had clinical pharmacist …

… patients by measuring the impact of the interventions on lipid profiles in a clinically challenging
peripheral arterial disease … week delivered by the trained clinical pharmacist (MH) who …

… Peripheral artery disease (PAD) is a highly prevalent atherosclerotic syndrome with an estimated
global population burden of ∼200 million people (1)… the public health impact of lifestyle …

… Importance Patients with peripheral arterial disease (PAD) … , no studies have examined the
effect of a comprehensive risk-… However, the effects of blood pressure control, lipid control, …

… that statin therapy in patients with peripheral artery disease (PAD) is … peripheral artery disease
(PAD) is a common vascular … The prevalence of PAD rises with age and affects 12–20% of …

… demonstrating atherosclerosis, peripheral arterial disease, or … event of a patient safety
issue (eg, serious adverse effect, chest … The CPCRS developed a hybridized protocol for lipid …

… for patients taking statins with those taking nonstatin lipid-… ) and found that those patients
taking nonstatin lipid therapy did not … The magnitude of this effect is clinically evident with the …

… cluster RCTs, that assesses the impact of a clinical pharmacy service on any type of health-…
disease, coronary artery disease, cerebrovascular disease, and peripheral vascular disease …

… evolocumab in patients with peripheral artery disease (PAD) as well as the effect on major …
manifestation of atherosclerotic vascular disease enjoy robust benefits from lipid lowering and …

… on coronary artery disease and stroke data. The aim of this study is to determine the effect of
statin … lipid lowering, and the pleiotropic effects of statins, as well, on atherosclerotic plaque. …